BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One. 2009;4:e5517. [PMID: 19436735 DOI: 10.1371/journal.pone.0005517] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Wassenaar TM. E. coli and colorectal cancer: a complex relationship that deserves a critical mindset. Critical Reviews in Microbiology 2018;44:619-32. [DOI: 10.1080/1040841x.2018.1481013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
2 Lucas C, Barnich N, Nguyen HTT. Microbiota, Inflammation and Colorectal Cancer. Int J Mol Sci 2017;18:E1310. [PMID: 28632155 DOI: 10.3390/ijms18061310] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 14.6] [Reference Citation Analysis]
3 Zheng S, Zhang S, Chen K, Zhu Y, Dong Q. Research on Colorectal Cancer in China. Recent Advances in Cancer Research and Therapy. Elsevier; 2012. pp. 535-95. [DOI: 10.1016/b978-0-12-397833-2.00019-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Dzutsev A, Goldszmid RS, Viaud S, Zitvogel L, Trinchieri G. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. European journal of immunology. 2015;45:17-31. [PMID: 25328099 DOI: 10.1002/eji.201444972] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 13.3] [Reference Citation Analysis]
5 Kidane D, Chae WJ, Czochor J, Eckert KA, Glazer PM, Bothwell AL, Sweasy JB. Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol 2014;49:116-39. [PMID: 24410153 DOI: 10.3109/10409238.2013.875514] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 10.8] [Reference Citation Analysis]
6 Lopez A, Hansmannel F, Kokten T, Bronowicki J, Melhem H, Sokol H, Peyrin-biroulet L. Microbiota in digestive cancers: our new partner? Carcinogenesis 2017;38:1157-66. [DOI: 10.1093/carcin/bgx087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
7 Fu M, Liang S, Wu J, Hua Y, Chen H, Zhang Z, Liu J, Li X, Zhang B, Zhao W, Wan C. An Escherichia coli Effector Protein EspF May Induce Host DNA Damage via Interaction With SMC1. Front Microbiol 2021;12:682064. [PMID: 34122393 DOI: 10.3389/fmicb.2021.682064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cao SS. Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2018;2018:7192646. [PMID: 30026758 DOI: 10.1155/2018/7192646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
9 Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut Microbes 2014;5:675-80. [PMID: 25483338 DOI: 10.4161/19490976.2014.969989] [Cited by in Crossref: 115] [Cited by in F6Publishing: 101] [Article Influence: 16.4] [Reference Citation Analysis]
10 Tian T, Wang Z, Zhang J. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies. Oxid Med Cell Longev 2017;2017:4535194. [PMID: 28744337 DOI: 10.1155/2017/4535194] [Cited by in Crossref: 144] [Cited by in F6Publishing: 139] [Article Influence: 28.8] [Reference Citation Analysis]
11 Raisch J, Buc E, Bonnet M, Sauvanet P, Vazeille E, de Vallée A, Déchelotte P, Darcha C, Pezet D, Bonnet R, Bringer MA, Darfeuille-Michaud A. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol 2014; 20(21): 6560-6572 [PMID: 24914378 DOI: 10.3748/wjg.v20.i21.6560] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 69] [Article Influence: 10.0] [Reference Citation Analysis]
12 Wang H, Zhang X, Sun W, Hu X, Li X, Fu S, Liu C. Activation of TIM1 induces colon cancer cell apoptosis via modulating Fas ligand expression. Biochemical and Biophysical Research Communications 2016;473:377-81. [DOI: 10.1016/j.bbrc.2016.02.085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
13 Manzat-Saplacan RM, Mircea PA, Balacescu L, Chira RI, Berindan-Neagoe I, Balacescu O. Can we change our microbiome to prevent colorectal cancer development? Acta Oncol 2015;54:1085-95. [PMID: 26073561 DOI: 10.3109/0284186X.2015.1054949] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
14 Hasan N, Pollack A, Cho I. Infectious causes of colorectal cancer. Infect Dis Clin North Am 2010;24:1019-39, x. [PMID: 20937463 DOI: 10.1016/j.idc.2010.07.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
15 Raisch J, Rolhion N, Dubois A, Darfeuille-Michaud A, Bringer MA. Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression. Lab Invest. 2015;95:296-307. [PMID: 25545478 DOI: 10.1038/labinvest.2014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Xiong YB, Zhu HR, Cheng YL, Yu ZH, Chai N. Gut microbiome and risk for colorectal cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(36): 5653-5658 [DOI: 10.11569/wcjd.v22.i36.5653] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Choi HJ, Kim J, Do KH, Park SH, Moon Y. Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells. Infect Immun 2013;81:1860-9. [PMID: 23403560 DOI: 10.1128/IAI.00162-13] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
18 Aituov B, Duisembekova A, Bulenova A, Alibek K. Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm? Infect Agent Cancer. 2012;7:18. [PMID: 22873119 DOI: 10.1186/1750-9378-7-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
19 Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis. Cancer Res 2017;77:27-40. [PMID: 27821485 DOI: 10.1158/0008-5472.CAN-16-1359] [Cited by in Crossref: 93] [Cited by in F6Publishing: 41] [Article Influence: 15.5] [Reference Citation Analysis]
20 Xu S, Yin W, Zhang Y, Lv Q, Yang Y, He J. Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer. Cancers (Basel) 2020;12:E372. [PMID: 32041122 DOI: 10.3390/cancers12020372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One. 2015;10:e0119462. [PMID: 25751261 DOI: 10.1371/journal.pone.0119462] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 14.6] [Reference Citation Analysis]
22 Park SH, Yu M, Kim J, Moon Y. C/EBP homologous protein promotes NSAID-activated gene 1-linked pro-inflammatory signals and enterocyte invasion by enteropathogenic Escherichia coli. Microbes Infect 2017;19:110-21. [PMID: 27771295 DOI: 10.1016/j.micinf.2016.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Sun J, Kato I. Gut microbiota, inflammation and colorectal cancer. Genes Dis. 2016;3:130-143. [PMID: 28078319 DOI: 10.1016/j.gendis.2016.03.004] [Cited by in Crossref: 107] [Cited by in F6Publishing: 91] [Article Influence: 17.8] [Reference Citation Analysis]
24 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
25 Raisch J, Rolhion N, Dubois A, Darfeuille-Michaud A, Bringer MA. Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression. Lab Invest. 2015;95:296-307. [PMID: 25545478 DOI: 10.1038/labinvest.2014.161] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
26 Dougherty MW, Jobin C. Shining a Light on Colibactin Biology. Toxins (Basel) 2021;13:346. [PMID: 34065799 DOI: 10.3390/toxins13050346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Gao X, Hardwidge PR. Ribosomal protein s3: a multifunctional target of attaching/effacing bacterial pathogens. Front Microbiol 2011;2:137. [PMID: 21738525 DOI: 10.3389/fmicb.2011.00137] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
28 He K, Zhao H, Wang Q, Pan Y. A comparative genome analysis of gene expression reveals different regulatory mechanisms between mouse and human embryo pre-implantation development. Reprod Biol Endocrinol 2010;8:41. [PMID: 20459759 DOI: 10.1186/1477-7827-8-41] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
29 Heinig RL, Paaijmans KP, Hancock PA, Thomas MB. The potential for fungal biopesticides to reduce malaria transmission under diverse environmental conditions. J Appl Ecol. 2015;52:1558-1566. [PMID: 26792946 DOI: 10.1007/s13668-012-0032-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Negut I, Grumezescu V, Grumezescu AM, Bîrcă AC, Holban AM, Urzica I, Avramescu SM, Gălățeanu B, Hudiță A. Nanostructured Thin Coatings Containing Anthriscus sylvestris Extract with Dual Bioactivity. Molecules 2020;25:E3866. [PMID: 32854362 DOI: 10.3390/molecules25173866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Sears CL, Pardoll DM. Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis. 2011;203:306-311. [PMID: 21208921 DOI: 10.1093/jinfdis/jiq061] [Cited by in Crossref: 123] [Cited by in F6Publishing: 119] [Article Influence: 10.3] [Reference Citation Analysis]
32 Taieb F, Petit C, Nougayrède J, Oswald E, Donnenberg MS. The Enterobacterial Genotoxins: Cytolethal Distending Toxin and Colibactin. EcoSal Plus 2016;7. [DOI: 10.1128/ecosalplus.esp-0008-2016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
33 Khan AA. In Silico Prediction of Escherichia coli Proteins Targeting the Host Cell Nucleus, with Special Reference to Their Role in Colon Cancer Etiology. Journal of Computational Biology 2014;21:466-75. [DOI: 10.1089/cmb.2014.0001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
34 Maddocks OD, Scanlon KM, Donnenberg MS. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. MBio. 2013;4:e00152-e00113. [PMID: 23781066 DOI: 10.1128/mbio.00152-13] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
35 Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe. 2014;15:317-328. [PMID: 24629338 DOI: 10.1016/j.chom.2014.02.007] [Cited by in Crossref: 430] [Cited by in F6Publishing: 391] [Article Influence: 53.8] [Reference Citation Analysis]
36 Dejea C, Wick E, Sears CL. Bacterial oncogenesis in the colon. Future Microbiol 2013;8:445-60. [PMID: 23534358 DOI: 10.2217/fmb.13.17] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
37 Watson KM, Gaulke CA, Tsikitis VL. Understanding the microbiome: a primer on the role of the microbiome in colorectal neoplasia. Ann Gastroenterol 2020;33:223-36. [PMID: 32382225 DOI: 10.20524/aog.2020.0467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Taddese R, Garza DR, Ruiter LN, de Jonge MI, Belzer C, Aalvink S, Nagtegaal ID, Dutilh BE, Boleij A. Growth rate alterations of human colorectal cancer cells by 157 gut bacteria. Gut Microbes 2020;12:1-20. [PMID: 32915102 DOI: 10.1080/19490976.2020.1799733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
39 Hirano T, Nakase H. The Multifaceted Effects of Gut Microbiota on the Immune System of the Intestinal Mucosa. Immuno 2021;1:583-94. [DOI: 10.3390/immuno1040041] [Reference Citation Analysis]
40 Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6:320-329. [PMID: 21850056 DOI: 10.1038/ismej.2011.109] [Cited by in Crossref: 601] [Cited by in F6Publishing: 567] [Article Influence: 54.6] [Reference Citation Analysis]
41 Kim J, Moon Y. Worm-Based Alternate Assessment of Probiotic Intervention against Gut Barrier Infection. Nutrients 2019;11:E2146. [PMID: 31500368 DOI: 10.3390/nu11092146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
42 Vipperla K, O’keefe SJ. Intestinal Microbes, Diet, and Colorectal Cancer. Curr Colorectal Cancer Rep 2013;9:95-105. [DOI: 10.1007/s11888-012-0158-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
43 Hernández-Luna MA, López-Briones S, Luria-Pérez R. The Four Horsemen in Colon Cancer. J Oncol 2019;2019:5636272. [PMID: 31662752 DOI: 10.1155/2019/5636272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
44 Trinchieri G. Innate inflammation and cancer: Is it time for cancer prevention? F1000 Med Rep 2011;3:11. [PMID: 21876717 DOI: 10.3410/M3-11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
45 Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol 2016; 22(2): 501-518 [PMID: 26811603 DOI: 10.3748/wjg.v22.i2.501] [Cited by in CrossRef: 323] [Cited by in F6Publishing: 277] [Article Influence: 53.8] [Reference Citation Analysis]
46 Maddocks OD, Scanlon KM, Donnenberg MS. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. MBio. 2013;4:e00152-e00113. [PMID: 23781066 DOI: 10.1128/mBio.00152-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Loke YL, Chew MT, Ngeow YF, Lim WWD, Peh SC. Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota. Front Cell Infect Microbiol 2020;10:603086. [PMID: 33364203 DOI: 10.3389/fcimb.2020.603086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
48 Conde-Pérezprina JC, León-Galván MÁ, Konigsberg M. DNA mismatch repair system: repercussions in cellular homeostasis and relationship with aging. Oxid Med Cell Longev 2012;2012:728430. [PMID: 23213348 DOI: 10.1155/2012/728430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
49 Rivas-Domínguez A, Pastor N, Martínez-López L, Colón-Pérez J, Bermúdez B, Orta ML. The Role of DNA Damage Response in Dysbiosis-Induced Colorectal Cancer. Cells 2021;10:1934. [PMID: 34440703 DOI: 10.3390/cells10081934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Levy M, Thaiss CA, Elinav E. The Microbiota: A New Player in the Etiology of Colorectal Cancer. Curr Colorectal Cancer Rep 2014;10:1-8. [DOI: 10.1007/s11888-013-0196-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 Roberto M, Carconi C, Cerreti M, Schipilliti FM, Botticelli A, Mazzuca F, Marchetti P. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon? Front Immunol 2021;12:704942. [PMID: 34489956 DOI: 10.3389/fimmu.2021.704942] [Reference Citation Analysis]
52 Boleij A, Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Philos Soc. 2012;87:701-730. [PMID: 22296522 DOI: 10.1111/j.1469-185x.2012.00218.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
53 Mughal MJ, Kwok HF. Multidimensional role of bacteria in cancer: Mechanisms insight, diagnostic, preventive and therapeutic potential. Semin Cancer Biol 2021:S1044-579X(21)00181-4. [PMID: 34119644 DOI: 10.1016/j.semcancer.2021.06.011] [Reference Citation Analysis]
54 Wu Y, Shi L, Li Q, Wu J, Peng W, Li H, Chen K, Ren Y, Fu X. Microbiota Diversity in Human Colorectal Cancer Tissues Is Associated with Clinicopathological Features. Nutrition and Cancer 2019;71:214-22. [DOI: 10.1080/01635581.2019.1578394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
55 Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer. The Lancet Oncology 2011;12:504-12. [DOI: 10.1016/s1470-2045(10)70186-8] [Cited by in Crossref: 87] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
56 Strickertsson JA, Desler C, Rasmussen LJ. Impact of bacterial infections on aging and cancer: impairment of DNA repair and mitochondrial function of host cells. Exp Gerontol. 2014;56:164-174. [PMID: 24704713 DOI: 10.1016/j.exger.2014.03.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
57 Robinson KM, Sieber KB, Dunning Hotopp JC. A review of bacteria-animal lateral gene transfer may inform our understanding of diseases like cancer. PLoS Genet 2013;9:e1003877. [PMID: 24146634 DOI: 10.1371/journal.pgen.1003877] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
58 Vossenkämper A, Macdonald TT, Marchès O. Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system. J Inflamm (Lond) 2011;8:11. [PMID: 21539730 DOI: 10.1186/1476-9255-8-11] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
59 Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10:717-725. [PMID: 22941505 DOI: 10.1038/nrmicro2873] [Cited by in Crossref: 784] [Cited by in F6Publishing: 746] [Article Influence: 78.4] [Reference Citation Analysis]
60 Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 2011;11:9-20. [PMID: 21151034 DOI: 10.1038/nri2891] [Cited by in Crossref: 251] [Cited by in F6Publishing: 247] [Article Influence: 20.9] [Reference Citation Analysis]
61 Skowron KB, Shogan BD, Rubin DT, Hyman NH. The New Frontier: the Intestinal Microbiome and Surgery. J Gastrointest Surg 2018;22:1277-85. [PMID: 29633119 DOI: 10.1007/s11605-018-3744-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
62 Han S, Gao J, Zhou Q, Liu S, Wen C, Yang X. Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review. Cancer Manag Res 2018;10:199-206. [PMID: 29440929 DOI: 10.2147/CMAR.S153482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
63 Veziant J, Gagnière J, Jouberton E, Bonnin V, Sauvanet P, Pezet D, Barnich N, Miot-Noirault E, Bonnet M. Association of colorectal cancer with pathogenic Escherichia coli: Focus on mechanisms using optical imaging. World J Clin Oncol 2016; 7(3): 293-301 [PMID: 27298769 DOI: 10.5306/wjco.v7.i3.293] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
64 Sang T, Qiu W, Li W, Zhou H, Chen H, Zhou H. The Relationship between Prevention and Treatment of Colorectal Cancer and Cancerous Toxin Pathogenesis Theory Basing on Gut Microbiota. Evid Based Complement Alternat Med 2020;2020:7162545. [PMID: 32774427 DOI: 10.1155/2020/7162545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Yu YN, Fang JY. Gut Microbiota and Colorectal Cancer. Gastrointest Tumors. 2015;2:26-32. [PMID: 26674881 DOI: 10.1159/000380892] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
66 Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One. 2013;8:e56964. [PMID: 23457644 DOI: 10.1371/journal.pone.0056964] [Cited by in Crossref: 232] [Cited by in F6Publishing: 211] [Article Influence: 25.8] [Reference Citation Analysis]
67 Khan S. Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer. Crit Rev Oncol Hematol 2015;96:475-82. [PMID: 26014615 DOI: 10.1016/j.critrevonc.2015.05.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
68 Gagnière J, Bonnin V, Jarrousse A, Cardamone E, Agus A, Uhrhammer N, Sauvanet P, Déchelotte P, Barnich N, Bonnet R, Pezet D, Bonnet M. Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer. Clinical Science 2017;131:471-85. [DOI: 10.1042/cs20160876] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
69 Blase JL, Campbell PT, Gapstur SM, Pawlita M, Michel A, Waterboer T, Teras LR. Prediagnostic Helicobacter pylori Antibodies and Colorectal Cancer Risk in an Elderly, Caucasian Population. Helicobacter 2016;21:488-92. [DOI: 10.1111/hel.12305] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
70 Hua Y, Yan K, Wan C. Clever Cooperation: Interactions Between EspF and Host Proteins. Front Microbiol 2018;9:2831. [PMID: 30524410 DOI: 10.3389/fmicb.2018.02831] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
71 Patel HG, Tabassum S, Shaikh S. E. coli Sepsis: Red Flag for Colon Carcinoma-A Case Report and Review of the Literature. Case Rep Gastrointest Med 2017;2017:2570524. [PMID: 28695023 DOI: 10.1155/2017/2570524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
72 Hamner S, Broadaway SC, Berg E, Stettner S, Pyle BH, Big Man N, Old Elk J, Eggers MJ, Doyle J, Kindness L, Good Luck B, Ford TE, Camper AC. Detection and source tracking of Escherichia coli, harboring intimin and Shiga toxin genes, isolated from the Little Bighorn River, Montana. Int J Environ Health Res 2014;24:341-62. [PMID: 24044742 DOI: 10.1080/09603123.2013.835030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
73 Hirano T, Hirayama D, Wagatsuma K, Yamakawa T, Yokoyama Y, Nakase H. Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis. Int J Mol Sci 2020;21:E3062. [PMID: 32357539 DOI: 10.3390/ijms21093062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
74 Han S, Zhuang J, Wu Y, Wu W, Yang X. Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites. Cancer Manag Res 2020;12:8703-20. [PMID: 33061569 DOI: 10.2147/CMAR.S268943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
75 Raisch J, Dalmasso G, Bonnet R, Barnich N, Bonnet M, Bringer MA. [How some commensal bacteria would exacerbate colorectal carcinogenesis?]. Med Sci (Paris) 2016;32:175-82. [PMID: 26936175 DOI: 10.1051/medsci/20163202011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
76 Choi HJ, Kim J, Do KH, Park SH, Moon Y. Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination. Oncogene 2013;32:4960-9. [PMID: 23503457 DOI: 10.1038/onc.2012.508] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
77 Hua Y, Ju J, Wang X, Zhang B, Zhao W, Zhang Q, Feng Y, Ma W, Wan C. Screening for host proteins interacting with Escherichia coli O157:H7 EspF using bimolecular fluorescence complementation. Future Microbiol 2018;13:37-58. [PMID: 29227212 DOI: 10.2217/fmb-2017-0087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
78 Khan AA, Cash P. E. coli and colon cancer: is mutY a culprit? Cancer Lett. 2013;341:127-131. [PMID: 23933175 DOI: 10.1016/j.canlet.2013.08.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]